Evidence map›Paper›PMID 31492594›Full record

ArticleThe Lancet. Child & adolescent health2019

Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study.

Mark G Thompson, Min Z Levine, Silvia Bino, Danielle R Hunt, Tareq M Al-Sanouri, Eric A F Simões, Rachael M Porter, Holly M Biggs, Lionel Gresh, Artan Simaku and 20 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The Lancet. Child & adolescent health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 15 institutions in 5 countries.

Mark G ThompsonInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: isq8@cdc.gov.
Min Z LevineInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Silvia BinoDepartment of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Danielle R HuntAbt Associates, Atlanta, GA, USA.
Tareq M Al-SanouriThe Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan.
Eric A F SimõesCenter for Global Health, Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA.
Rachael M PorterInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Holly M BiggsDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lionel GreshSustainable Sciences Institute, Managua, Nicaragua.
Artan SimakuDepartment of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Illham Abu KhaderThe Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan.
Veronica L TalloResearch Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines.
Jennifer K MeeceMarshfield Clinic Research Foundation, Marshfield, WI, USA.
Meredith McMorrowInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Edelwisa S MercadoResearch Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines.
Sneha JoshiInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Nicholas P DeGrooteDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Iris HatibiDepartment of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Felix SanchezHospital Infantil Manuel de Jesus Rivera, Ministry of Health, Managua, Nicaragua.
Marilla G LuceroResearch Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines.
Samir FaouriAl Bashir Hospital, Ministry of Health, Amman, Jordan.
Stacie N JeffersonInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Numila MaliqariGeneral Pediatrics Unit, University Hospital Center "Mother Teresa", Tirana, Albania.
Angel BalmasedaLaboratorio Nacional de Virologia, Centro Nacional de Diagnostico y Referencia, Ministry of Health, Managua, Nicaragua.
Diozele SanvictoresResearch Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines.
Crystal HolidayInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cristina SciutoAbt Associates, Atlanta, GA, USA.
Zachary OwensInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Eduardo Azziz-BaumgartnerInfluenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Aubree GordonDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
National Center for Immunization and Respiratory Diseases · USCenters for Disease Control and Prevention · USResearch Institute for Tropical Medicine · PHAbt Global (United States) · USEastern Mediterranean Public Health Network · JOUniversity of Medicine Tirana · ALCenter for Global Health · USHospital Infantil Manuel de Jesús Rivera · NIInstitute of Public Health · ALMarshfield Clinic · USMinistry of Health · JOMother Teresa Hospital · ALNational Autonomous University of Nicaragua · NISustainable Sciences Institute · USUniversity of Michigan–Ann Arbor · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundSince influenza often presents non-specifically in infancy, we aimed to assess the extent to which existing respiratory surveillance platforms might underestimate the frequency of severe influenza disease among infants.

methodsThe Influenza and Respiratory Syncytial Virus in Infants (IRIS) study was a prospective observational study done at four hospitals in Albania, Jordan, Nicaragua, and the Philippines. We included acutely ill infants aged younger than 1 year admitted to hospital within 10 days or less of illness onset during two influenza seasons (2015-16 and 2016-17) in Albania, Jordan, and Nicaragua, and over a continuous 34 week period (2015-16) in the Philippines. We assessed the frequency of influenza virus infections by real-time RT-PCR (rRT-PCR) and serology. The main study outcome was seroconversion, defined as convalescent antibody titres more than or equal to four-fold higher than acute sera antibody titres, and convalescent antibody titres of 40 or higher. Seroconverison was confirmed by haemagglutination inhibition assay for influenza A viruses, and by hemagglutination inhibition assay and microneutralisation for influenza B viruses.

findingsBetween June 27, 2015, and April 21, 2017, 3634 acutely ill infants were enrolled, of whom 1943 were enrolled during influenza seasons and had complete acute-convalescent pairs and thus were included in the final analytical sample. Of the 1943 infants, 94 (5%) were influenza-positive by both rRT-PCR and serology, 58 (3%) were positive by rRT-PCR-only, and 102 (5%) were positive by serology only. Seroconversion to at least one of the influenza A or B viruses was observed among 196 (77%) of 254 influenza-positive infants. Of the 254 infants with influenza virus, 84 (33%) only had non-respiratory clinical discharge diagnoses (eg, sepsis, febrile seizures, dehydration, or other non-respiratory viral illness). A focus on respiratory diagnoses and rRT-PCR-confirmed influenza underdetects influenza-associated hospital admissions among infants by a factor of 2·6 (95% CI 2·0-3·6). Findings were unchanged when syndromic severe acute respiratory infection criteria were applied instead of clinical diagnosis.

interpretationIf the true incidence of laboratory-confirmed influenza-associated hospital admissions among infants is at least twice that of previous estimates, this substantially increases the global burden of severe influenza and expands our estimates of the preventive value of maternal and infant influenza vaccination programmes.

fundingUS Centers for Disease Control and Prevention.

Indexed as

AlbaniaAntibodies, ViralDNA, ViralFemaleFollow-Up StudiesHumansIncidenceInfantInfant, NewbornInfluenza B virusInfluenza, HumanJordanMaleNicaraguaPatient AdmissionPopulation SurveillanceAntibodies, ViralDNA, Viral

Identifiers

PMID31492594
PMCPMC7029431
OpenAlexW2971379795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.